ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

NCT05830123 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteosarcoma
Sarcoma

Interventions

DRUG: HS-20093

Sponsor

Hansoh BioMedical R&D Company